Matthew Norwood, VP of Sales at OBALON THERAPEUTICS INC (OBLN), bought 1,000 shares at $15.00 ($15K) on 2016-10-12, disclosed to the SEC on 2016-10-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.